Psychiatry & Neurology, Clinical Neurophysiology · San Antonio, TX
NPI
1093881591
Since 2006
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8300 Floyd Curl Dr
San Antonio, TX, 78229
Phone (210) 450-9000
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
377 services
Medicare patients, 2024
161
Average age 60
Drug cost, 2024
$1.4M
2,788 prescriptions
Company payments, 2025
$241
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kameel M Karkar was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 78 times for 59 patients. In total Kameel M Karkar billed 377 services in 22 codes, and Medicare paid $27K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-05.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 78 | 59 | $11.38 | $887 |
| 99214 Office E&M - Established | Office | 63 | 51 | $77.24 | $4,866 |
| 95720 Neurologic | Facility | 52 | 25 | $163.20 | $8,487 |
| 95816 Neurologic | Facility | 31 | 30 | $44.28 | $1,373 |
| 99215 Office E&M - Established | Office | 25 | 22 | $123.20 | $3,080 |
| 95822 Neurologic | Facility | 19 | 19 | $45.58 | $866 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 19 | 12 | $9.93 | $189 |
| 95813 Neurologic | Facility | 15 | 15 | $59.93 | $899 |
| 99214 Office E&M - Established | Facility | 13 | 11 | $48.97 | $637 |
By year: 2022 $35K for 371 services; 2023 $32K for 341 services; 2024 $27K for 377 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kameel M Karkar prescribed most often to Medicare patients was Levetiracetam, with 435 prescriptions and refills. In total Kameel M Karkar wrote 2,788 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 435 | 1,043 | 114 | $28K |
| Lacosamide Generic | 357 | 626 | 69 | $67K |
| Lamotrigine Generic | 280 | 646 | 59 | $7,729 |
| Clobazam Generic | 192 | 379 | 47 | $53K |
| Zonisamide Generic | 140 | 316 | 35 | $5,276 |
| Topiramate Generic | 119 | 234 | 25 | $2,793 |
| Lorazepam Generic | 100 | 121 | 33 | $1,371 |
| Epidiolex Cannabidiol (Cbd) | 100 | 111 | 16 | $424K |
| Clonazepam Generic | 91 | 122 | 19 | $1,250 |
| Briviact Brivaracetam | 90 | 110 | 18 | $155K |
| Oxcarbazepine Generic | 70 | 152 | 17 | $11K |
| Carbamazepine Er Carbamazepine | 69 | 137 | Under 11 | $11K |
| Nayzilam Midazolam | 64 | 66 | 27 | $68K |
| Fycompa Perampanel | 53 | 75 | Under 11 | $77K |
| Divalproex Sodium Generic | 50 | 80 | 13 | $2,686 |
Brand drugs: 528 claims; generic drugs: 2,224 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kameel M Karkar $241 ($241 in general payments such as food, travel and fees) from 4 companies. The largest payer was Ipsen Biopharmaceuticals, Inc with $123.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.